WRAP TECHNOLOGIES, INC. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Wrap Technologies, Inc. on November 5, 2018, covering events occurring on October 30, 2018. The filing details a private placement offering of equity securities to accredited investors.
Key Financial Metrics and Transaction Details
- Units Sold: 4,561,074 units.
- Price Per Unit: $3.00.
- Unit Composition: One share of Common Stock and a two-year warrant to purchase one share at $5.00.
- Gross Proceeds: Approximately $13,683,222 (calculated from units and price).
- Net Proceeds: Approximately $12,140,000 after deducting commissions, fees, and expenses.
- Placement Agent Fees: Katalyst Securities LLC received a cash fee of approximately $1,368,304, $100,000 in expenses, and a warrant to purchase 456,107 shares (10% of units sold) at $3.00 per share.
- Use of Proceeds: Product development, manufacturing, sales, marketing, and general working capital.
Material Changes
The filing reports the entry into Material Definitive Agreements and Unregistered Sales of Equity Securities. The Company entered into Subscription Agreements and Registration Rights Agreements with purchasers. The Company agreed to file a registration statement with the SEC within 30 days of the closing date to register the shares and warrants issued.
Outlook, Risks, and Contingencies
The securities were issued in reliance on exemptions under Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D. The shares and warrants are not registered and may not be offered or sold in the United States unless registered or an exemption is available. The filing incorporates a press release issued on October 31, 2018, regarding the offering.
Investor Verification Checklist
- Verify the final number of shares issued and the exact net proceeds received.
- Confirm the filing of the registration statement within the required 30-day window post-closing.
- Review the full text of the Subscription Agreement (Exhibit 10.1) and Registration Rights Agreement (Exhibit 10.2) for specific covenants.
- Assess the dilution impact of the 4,561,074 new shares and the associated warrants.
- Monitor the Company's actual deployment of the $12.14 million in net proceeds against the stated uses.